Page 2439 - Williams Hematology ( PDFDrive )

2410 Index Index 2411

Catastrophic antiphospholipid syndrome in HIV infection, 1240 in follicular lymphoma, 1642
(CAPS), 2239, 2245 in Hodgkin lymphoma, 1607 lymphoid progenitors and, 1153
Cathelicidins, 1014 in immune cell therapy, 409, 411 in Waldenström macroglobulinemia, 1785,
Cathepsin B, 523 immune response and, 423t 1791
Cathepsin C (dipeptidyl peptidase 1), 1013 minor histocompatibility antigens and, CD11a (LFA-1)
Cathepsin G, 283, 1012t, 1013, 1856 413–414 in diffuse large B-cell lymphoma, 1627
Catheter-directed thrombolysis, 2278 subsets, 1180–1182, 1181f expression, 1056
Cationic proteins, 284t CD4+CD25+ T cells. See CD4+CD25+ human neutrophil antigens and, 2358
Cat-scratch fever, 818, 1268 regulatory T (T REG ) cells in inflammation, 1977t
CBF, 1376, 1377 T cells, 1182 in monocytes, 1056, 1078
FH
CBL, 228t, 229t, 1352 Th1 and Th2 cells, 1180 in myeloma, 1712
CBL/CBLB, 1346t Th9 cells, 1182 structure, 1056
CBV regimen, for Hodgkin lymphoma, 1616 Th17 cells, 1182 CD11a/CD18, 282, 1083
CC chemokines, 288, 288t CD5 CD11b (C3)
ccff-DNA (circulating cell-free fetal DNA), in diffuse large B-cell lymphoma, 1627 in acute basophilic leukemia, 1393
852 in mantle cell lymphoma, 1593, 1653 in acute myelogenous leukemia, 1380t,
CCL2 (monocyte chemoattractant protein, in prolymphocytes, 1542 1383
MCP-1) in thymocytes, 1141 antibodies, 1056
in atherosclerosis, 2283, 2284f, 2286, 2287 in Waldenström macroglobulinemia, 1785, in antiphospholipid syndrome, 2237
basophils and, 288t 1791 in atypical hemolytic uremic syndrome,
in chronic myelogenous leukemia, 1440 CD5+ B cells, 1141, 1495t 2259–2260
monocyte activity and, 288, 288t, 2286 CD7, 1153 in B-cell development, 1151
CCL5 (RANTES), 1607, 1852f, 1855, 2286 CD7, 1643 in cell signaling, 1015
CCL17, 1607 CD8 expression, 1056
CCL22, 1607 function, 1179 in immune thrombocytopenia, 2000
CCND1, 187, 234t, 236t in natural killer cells, 1142 in leukocyte adhesion deficiency, 1023
CCND2, 1632 in peripheral T-cell lymphoma, 1697 in monocytes, 1054, 1056
CCND3, 1672 in precursor thymocytes, 1179 in neutrophils, 1024, 2358
CCR. See under Chemokine receptor structure, 1179 CD11b/CD18 (Mac-1, Mo1, CR3, α β )
M 2
CCyR (complete cytogenic response), 1452t CD8B1, 1643 in eosinophils, 948
CD1, 308–309, 1177 CD8+CD28- T-cell population, in aplastic human neutrophil antigens and, 2357t,
CD1a–e, 308–309 anemia, 515 2358
CD2 (LFA-2), 1185, 1185f CD8+ T cells (cytotoxic T lymphocytes, in inflammation, 282, 283
CD3, 1142, 1143, 1176f CTLs) in leukocyte–platelet and endothelial
CD3γ chain, 1178 activation, 308 cell–platelet interactions, 1977t,
CD3δ chain, 1178 antigens, 1142t 1978–1979, 1979t
CD3ε chain, 1178 in cellular therapy, 409–410, 412 in monocytes/macrophages, 1052f, 1053f,
CD4 cytoplasmic granules in, 1145 1059, 1083
function, 1179 defects in, 1227–1228 in neutrophils, 1007, 1013t
in HIV infection, 1240 epitopes, vaccine therapy and, 421 CD11c, 1056, 1383
in lymphocytes, 1142, 1143 function, 1179–1180 CD11c+, 1082
in monocytes and macrophages, in HIV infection, 1240 CD11c/CD18, 282–283
1056–1057 immune response and, 423t CD11/CD18, 1015, 1021–1022, 1023f
in peripheral T-cell lymphoma, 1697 in lymphocyte activation, 1139 CD13
in precursor thymocytes, 1179 minor histocompatibility antigens and, in acute lymphoblastic leukemia, 1512
structure, 1052f, 1179 413–414 in acute myelogenous leukemia, 1380t,
CD4+CD25+ regulatory T (T REG ) cells in mycosis fungoides, 1682f 1383
in aplastic anemia, 515 in spleen, 863 leukemoid reaction and, 986
in chronic lymphocytic leukemia, 1528 in T-cell large granular lymphocytic in lymphocytes, 1144t
eosinophils and, 950 leukemia, 1563, 1565f in monocytes, 271
functions, 1180–1182 CD9, 1393, 1836, 1871 CD14
in immune thrombocytopenia, 2000 CD10 (CALLA) in acute monocytic leukemia, 1391
CD4+ T cells (helper T cells), 409 in angioimmunoblastic T-cell lymphoma, in acute myelogenous leukemia, 1380t,
antigens, 1142t 1698 1383
depletion, idiopathic, 1206 in diffuse large B-cell lymphoma, 1627 in innate immunity, 294t, 296f
epitopes, vaccine therapy and, 421 ectoenzyme activity, 1143, 1144t in lymphoid progenitors, 1153

Kaushansky_index_p2393-2506.indd 2410 9/21/15 3:21 PM